# Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)

> **NCT06391749** · — · ENROLLING_BY_INVITATION · sponsor: **Gene Solutions** · enrollment: 1000 (estimated)

## Conditions studied

- Cancer Colon
- Cancer, Liver
- Cancer, Lung
- Cancer, Breast
- Cancer, Gastric

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06391749
- **Lead sponsor:** Gene Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-07-30
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06391749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06391749, "Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06391749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*